Samuel Fayne Victory from Winston Salem, NC, age 58

view source

Aryl Substituted Pyridines And The Use Thereof
view source
US Patent:

7105549, Sep 12, 2006
Filed:

Sep 6, 2002
Appl. No.:

10/235673
Inventors:

Bin Shao - Richboro PA, US
R. Richard Goehring - Pipersville PA, US
Samuel F Victory - Newtown PA, US
Qun Sun - Princeton NJ, US
Assignee:

Euro-Celtique S.A. - Luxembourg
International Classification:

A61K 31/443
A61K 31/4439
A61K 31/451
C07D 213/60
C07D 401/04
C07D 405/04
C07D 413/04
US Classification:

514341, 514343, 514345, 514352, 514354, 514357, 5462721, 5462724, 5462727, 5462754, 546290, 546304, 546313, 546314, 546329, 546339
Abstract:

This invention relates aryl substituted pyridines of Formula I:.

Aryl Substituted Pyridines And The Use Thereof
view source
US Patent:

7579367, Aug 25, 2009
Filed:

Sep 11, 2006
Appl. No.:

11/518448
Inventors:

Bin Shao - Richboro PA, US
R. Richard Goehring - Pipersville PA, US
Samuel F. Victory - Oak Ridge NC, US
Assignee:

Purdue Pharma L.P. - Stamford CT
International Classification:

A61K 31/4418
C07D 213/26
US Classification:

514355, 546339
Abstract:

This invention relates aryl substituted pyridines of Formula I:.

Substituted Heteroaryl Derivatives, Compositions, And Methods Of Use
view source
US Patent:

7820704, Oct 26, 2010
Filed:

Apr 20, 2005
Appl. No.:

11/110499
Inventors:

Adnan M. M. Mjalli - Jamestown NC, US
Bapu R. Gaddam - Greensboro NC, US
Ghassan Qabaja - High Point NC, US
Govindan Subramanian - High Point NC, US
Jeff Zhu - Greensboro NC, US
John Dankwardt - Westborough MA, US
Murty N. Arimilli - Oak Ridge NC, US
Robert C. Andrews - Jamestown NC, US
Samuel Victory - Oak Ridge NC, US
Ye E. Tian - Jamestown NC, US
Assignee:

TransTech Pharma, Inc. - High Point NC
International Classification:

A61K 31/427
A61K 31/381
C07D 277/38
C07D 409/12
US Classification:

514370, 514444, 548194, 549 59
Abstract:

The present invention provides substituted heteroaryl derivatives of Formula (I), methods of their preparation, pharmaceutical compositions comprising the compounds of Formula (I), and methods of use in treating human or animal disorders. The compounds of the invention can be useful as inhibitors of action of AgRP on a melanocortin receptor and thus can be useful for the management, treatment, control, or the adjunct treatment of diseases which may be responsive to the modulation of melanocortin receptors including obesity-related disorders.

Aryl Substituted Pyridines And The Use Thereof
view source
US Patent:

7943643, May 17, 2011
Filed:

Aug 24, 2009
Appl. No.:

12/546572
Inventors:

Bin Shao - Richboro PA, US
R. Richard Goehring - Pipersville PA, US
Samuel F. Victory - Newtown PA, US
Assignee:

Purdue Pharma L.P. - Stamford CT
International Classification:

A61K 31/4418
C07D 213/26
US Classification:

514355, 546339
Abstract:

This invention relates aryl substituted pyridines of Formula I:.

Substituted Aminothiazole Derivatives, Pharmaceutical Compositions, And Methods Of Use
view source
US Patent:

8563742, Oct 22, 2013
Filed:

Aug 25, 2009
Appl. No.:

12/547018
Inventors:

Adnan M. M. Mjalli - Oak Ridge NC, US
Bapu Gaddam - High Point NC, US
Robert C. Andrews - Jamestown NC, US
Samuel Victory - Oak Ridge NC, US
Suparna Gupta - Greensboro NC, US
Assignee:

High Point Pharmaceuticals, LLC - High Point NC
International Classification:

A61K 31/427
C07D 417/12
US Classification:

548194, 514370
Abstract:

Substituted aminothiazole derivatives, methods of their preparation, pharmaceutical compositions comprising a substituted aminothiazole, and methods of use in treating human or animal disorders. The compounds may be useful as inhibitors of action of AgRP on a melanocortin receptor and thus may be useful for the management, treatment, control, or the adjunct treatment of diseases which may be responsive to the modulation of melanocortin receptors including obesity-related disorders.

2-Substituted Bicyclic Benzoheterocyclic Compounds And Their Use As Sodium Channel Blockers
view source
US Patent:

20040152696, Aug 5, 2004
Filed:

Jul 29, 2003
Appl. No.:

10/628487
Inventors:

Qun Sun - Princeton NJ, US
Donald Kyle - Newtown PA, US
Samuel Victory - Newtown PA, US
Assignee:

Euro-Celtique S.A.
International Classification:

A61K031/5415
A61K031/517
C07D279/16
C07D239/72
US Classification:

514/224200, 514/266300, 544/050000, 544/287000, 514/266310
Abstract:

This invention relates to a method of treating disorders responsive to the blockade of sodium ion channels using novel 2-substituted bicyclic benzoheterocyclic compounds of Formula I: or a pharmaceutically-acceptable salt or solvate thereof, wherein X is —NH—, —N or —S—, Y is oxygen or sulfur, and n, p, R, R, Rand Rare defined in the specification. The invention is also directed to the use of compounds of Formula I for the treatment of neuronal damage following global or focal ischemia, for the treatment or prevention of neurodegenerative conditions such as amyotrophic lateral sclerosis (ALS), and for the treatment, prevention or amelioration of acute or chronic pain, neuropathic pain or surgical pain, as antitinnitus agents, as anticonvulsants, and as antimanic depressants, as local anesthetics, as antiarrhythmics and for the treatment or prevention of diabetic neuropathy.

Substituted Fused Imidazole Derivatives, Pharmaceutical Compositions, And Methods Of Use Thereof
view source
US Patent:

20110201604, Aug 18, 2011
Filed:

Feb 16, 2011
Appl. No.:

13/028406
Inventors:

Adnan M. M. Mjalli - Oak Ridge NC, US
Dharma Rao Polisetti - High Point NC, US
Jareer Nabeel Kassis - Colfax NC, US
Matthew J. Kostura - Hillsborough NC, US
Mustafa Guzel - Jamestown NC, US
Otis Clinton Attucks - Winston-Salem NC, US
Robert Carl Andrews - Jamestown NC, US
Samuel Victory - Oak Ridge NC, US
Suparna Gupta - Greensboro NC, US
Assignee:

HIGH POINT PHARMACEUTICALS, LLC - High Point NC
International Classification:

A61K 31/428
C07D 417/12
C07D 417/14
A61K 31/5377
C07D 471/04
A61K 31/437
A61K 31/454
A61K 31/496
A61K 31/541
A61K 31/506
A61P 11/00
A61P 1/16
A61P 31/12
A61P 17/06
A61P 17/00
A61P 25/28
A61P 25/16
A61P 9/12
A61P 9/00
A61P 7/02
A61P 29/00
A61P 11/06
A61P 13/12
A61P 27/02
A61P 3/10
A61P 3/04
A61P 35/00
US Classification:

5142282, 548159, 514367, 544135, 5142345, 546118, 514303, 544127, 5142342, 546199, 514322, 544370, 51425402, 544 584, 544 582, 544316, 514274
Abstract:

Substituted fused imidazole derivatives, methods of their preparation, pharmaceutical compositions comprising a substituted fused imidazole derivative, and methods of use in treating inflammation are provided. The substituted fused imidazole derivatives may control the activity or the amount or both the activity and the amount of heme-oxygenase.